A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension
Clinical trial NCT06328400 · COMPLETED
Trial details
- NCT number
- NCT06328400
- Sponsor
- Vigonvita Life Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2024-05-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.